Gene · 4154
Papers2,262
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,262
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells. | Stem Cell Res Ther | 2024 | 39278936 | PubTator, text mining | PubMed |
| MBNL splicing factors regulate the microtranscriptome of skeletal muscles. | Nucleic Acids Res | 2024 | 39258536 | PubTator, text mining | PubMed |
| Improving protein function prediction by learning and integrating representations of protein sequences and function labels. | Bioinform Adv | 2024 | 39233898 | PubTator, text mining | PubMed |
| Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1. | Hum Mol Genet | 2024 | 39180495 | PubTator, text mining | PubMed |
| A CRISPR-dCas13 RNA-editing tool to study alternative splicing. | Nucleic Acids Res | 2024 | 39162234 | PubTator, text mining | PubMed |
| CircCNNs, a convolutional neural network framework to better understand the biogenesis of exonic circRNAs. | Sci Rep | 2024 | 39152135 | PubTator, text mining | PubMed |
| Optimizing cancer patient care with a robust assay for 5-fluorouracil quantification and in-vitro stability in human blood for therapeutic drug monitoring. | Pract Lab Med | 2024 | 39132451 | PubTator, text mining | PubMed |
| Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study. | J Neuromuscul Dis | 2024 | 39031377 | PubTator, text mining | PubMed |
| Predicting protein functions using positive-unlabeled ranking with ontology-based priors. | Bioinformatics | 2024 | 38940168 | PubTator, text mining | PubMed |
| Identification of miRNA expression profile in middle ear cholesteatoma using small RNA-sequencing. | BMC Med Genomics | 2024 | 38890701 | PubTator, text mining | PubMed |
| Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity. | iScience | 2024 | 38832025 | PubTator, text mining | PubMed |
| Computational approaches and challenges in the analysis of circRNA data. | BMC Genomics | 2024 | 38807085 | PubTator, text mining | PubMed |
| DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. | Kidney Int | 2024 | 38782200 | PubTator, text mining | PubMed |
| Lineage-specific splicing regulation of MAPT gene in the primate brain. | Cell Genom | 2024 | 38772368 | PubTator, text mining | PubMed |
| Involvement of circRNA Regulators MBNL1 and QKI in the Progression of Esophageal Squamous Cell Carcinoma. | Cancer Control | 2024 | 38769028 | PubTator, text mining | PubMed |
| A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer. | Clin Transl Med | 2024 | 38725048 | PubTator, text mining | PubMed |
| Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration. | Int J Mol Sci | 2024 | 38473933 | PubTator, text mining | PubMed |
Statement of Retraction: Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis. | Bioengineered | 2024 | 38376423 | PubTator, text mining | PubMed |
| Functional requirement of alternative splicing in epithelial-mesenchymal transition of pancreatic circulating tumor. | Mol Ther Nucleic Acids | 2024 | 38370981 | PubTator, text mining | PubMed |
| Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. | EClinicalMedicine | 2024 | 38314057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4154/papers?page=6